Target intelligence / Profile preview

Antioxidant and redox-related pathways

Molecular classification
Transcription factor, Enzyme, Other
01

Overview

Antioxidant and redox-related pathways represent a broad network of molecular systems designed to maintain cellular redox homeostasis by neutralizing reactive oxygen species (ROS) and reactive nitrogen species (RNS) [3.2.1, 3.2.5]. Central to these pathways is the Nrf2-Keap1 signaling axis, which orchestrates the expression of numerous cytoprotective and antioxidant genes, including those for superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx) [3.2.2, 3.2.5]. While physiological levels of ROS are vital for signal transduction and immune defense, an imbalance favoring pro-oxidants leads to oxidative stress, causing damage to DNA, proteins, and lipids [3.2.1, 3.2.4]. This dysregulation is a hallmark of various pathologies, including cancer, neurodegenerative diseases like Alzheimer's, and cardiovascular disorders [3.1.1, 3.2.5]. Therapeutic strategies targeting these pathways include Nrf2 activators such as dimethyl fumarate and ROS scavengers like N-acetylcysteine, which aim to restore balance and mitigate tissue damage [3.1.5, 3.2.2]. However, clinical application is complicated by the risk of 'reductive stress' and the potential for antioxidants to inadvertently protect malignant cells from oxidative-stress-induced apoptosis [3.1.3, 3.2.3].

Other names
Redox signaling pathwaysAntioxidant defense systemOxidative stress pathwaysRedox homeostasis pathways
02

Mechanism of action

Modulation of redox-sensitive transcription factors (e.g., Nrf2 activation), direct scavenging of reactive oxygen species (ROS), and inhibition of ROS-generating enzymes such as NADPH oxidase (NOX).

03

Biological functions

Signal transductionApoptosisCell proliferationMetabolismImmune responseCell death
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesChronic kidney disease
05

Safety considerations

Reductive stress from excessive antioxidant activityInterference with essential physiological ROS signalingPotential to promote survival and chemoresistance in cancer cells (Nrf2 paradox)Lack of tissue specificity leading to systemic side effects
06

Interacting drugs

Bardoxolone methyl

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)F2-isoprostanesGSH/GSSG ratioNrf2 expressionSuperoxide dismutase (SOD) activity

Beyond the preview

Go deeper on Antioxidant and redox-related pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidant and redox-related pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call